Page 47 - Ryan Weispfenning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim™ SureScan™ MRI Leads News provided by Share this article Share this article DUBLIN, Feb. 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration (FDA) for expanded MRI labeling of its InterStim™ II and InterStim™ Micro sacral neuromodulation (SNM) systems that use SureScan™ MRI leads. The updated MRI Guidelines allow for a wider range of MRI scan parameters and shorter wait time betwee...

Medtronic Executives to Speak at Upcoming Investor Conferences News provided by Share this article Share this article DUBLIN, Feb. 17, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences, with its executives answering questions about the company: 10 Wednesday, February 24, 2021, at 9:20 am EST Speaker: Mike Weinstein, senior vice president of strategy Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Thursday, February 25, 2021, at 2:25 pm ...

Medtronic Recognized as One of Fortune's 2021 World's Most Admired Companies News provided by Share this article Global Leader in Medical Technology Ranks #4 in Industry on Annual List DUBLIN, Feb. 1, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) has been named to FORTUNE's 2021 World's Most Admired Companies List. The global leader in medical technology landed at #4 in the Medical Products and Equipment industry. "We're honored to once again be selected by Fortune for this prestigious recognition," said Geoff Martha, Medtronic chairman and chief executive officer. "Every day, our teams aro...

Medtronic Receives FDA Approval of DiamondTemp Ablation System for the Treatment of Patients with Atrial Fibrillation Clinical Trial Demonstrates Procedural Efficiencies, Safety, Effectiveness and Non-Inferiority of DiamondTemp System News provided by Share this article Share this article DUBLIN, Jan. 29, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of the DiamondTemp™ Ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial fibrillati...

Parkinson's Disease), its trial evaluating the safety and efficacy of adaptive deep brain stimulation (aDBS) in patients with Parkinson's Disease (PD). Adaptive deep brain stimulation is an investigational feature of the Percept™ PC device that could be enabled if approved. The investigational feature used in this study allows for automated adjustment of brain stimulation to provide therapy to manage symptoms of Parkinson's disease based on a patient's clinical state. The randomized study will take place across 12 study sites at leading Movement Disorders research centers in the United S...